Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III comparison of Salmex versus Seretide in adults with bronchial asthma
ChiCTR2000033750Phase 3Not yet recruiting
- Sponsor
- The First Affiliated Hospital of Guangzhou Medical University
- Start
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of salmeterol + fluticasone in asthma (2 arms), sponsored by The First Affiliated Hospital of Guangzhou Medical University. Primary endpoint: FEV1. Planned start Jun 2020; status: not yet recruiting.
02
Drugs
salmeterol + fluticasone
03
Conditions
asthma
Beyond the preview
Go deeper on ChiCTR2000033750.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000033750.